BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19864818)

  • 1. Alpha-1-antitrypsin deficiency: an overview of recent advances.
    El Hazmi MA
    Saudi J Gastroenterol; 1996 Sep; 2(3):113-9. PubMed ID: 19864818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural administration of a serotype 5 adeno-associated virus coding for alpha1-antitrypsin mediates persistent, high lung and serum levels of alpha1-antitrypsin.
    De B; Heguy A; Leopold PL; Wasif N; Korst RJ; Hackett NR; Crystal RG
    Mol Ther; 2004 Dec; 10(6):1003-10. PubMed ID: 15564132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha1-Antitrypsin deficiency is not an important cause of childhood liver diseases in a multi-ethnic Southeast Asian population.
    Lee WS; Yap SF; Looi LM
    J Paediatr Child Health; 2007 Sep; 43(9):636-9. PubMed ID: 17688648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
    J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.
    Chiuchiolo MJ; Kaminsky SM; Sondhi D; Hackett NR; Rosenberg JB; Frenk EZ; Hwang Y; Van de Graaf BG; Hutt JA; Wang G; Benson J; Crystal RG
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):161-73. PubMed ID: 24191907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-antitrypsin deficiency and related liver disease.
    Elzouki AN
    Saudi J Gastroenterol; 1999 Jan; 5(1):1-8. PubMed ID: 19864752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha1-antitrypsin deficiency: biological answers to clinical questions.
    Coakley RJ; Taggart C; O'Neill S; McElvaney NG
    Am J Med Sci; 2001 Jan; 321(1):33-41. PubMed ID: 11202478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease.
    Sharp HL
    Gastroenterology; 1976 Apr; 70(4):611-21. PubMed ID: 767197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency.
    Novoradovskaya N; Lee J; Yu ZX; Ferrans VJ; Brantly M
    J Clin Invest; 1998 Jun; 101(12):2693-701. PubMed ID: 9637703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.
    Gadek JE; Fulmer JD; Gelfand JA; Frank MM; Petty TL; Crystal RG
    J Clin Invest; 1980 Jul; 66(1):82-87. PubMed ID: 6967489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha-1-antitrypsin deficiency].
    Bouchecareilh M
    Med Sci (Paris); 2014 Oct; 30(10):889-95. PubMed ID: 25311024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency.
    Hill AT; Bayley DL; Campbell EJ; Hill SL; Stockley RA
    Eur Respir J; 2000 May; 15(5):886-90. PubMed ID: 10853853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
    Blank CA; Brantly M
    Ann Allergy; 1994 Feb; 72(2):105-20; quiz 120-2. PubMed ID: 8109800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha1-Antitrypsin deficiency: best clinical practice.
    Kalsheker NA
    J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A future for neonatal alpha1-antitrypsin screening?
    Sveger T; Thelin T
    Acta Paediatr; 2000 Mar; 89(3):259-61. PubMed ID: 10772268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha1-antitrypsin gene mutation hot spot associated with the formation of a retained and degraded null variant [corrected; erratum to be published].
    Brantly M; Lee JH; Hildesheim J; Uhm CS; Prakash UB; Staats BA; Crystal RG; Hildeshiem J
    Am J Respir Cell Mol Biol; 1997 Mar; 16(3):225-31. PubMed ID: 9070606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
    Finotti P; de Laureto PP
    Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of human alpha-1-antitrypsin.
    Sifers RN; Shen RF; Woo SL
    Mol Biol Med; 1989 Apr; 6(2):127-35. PubMed ID: 2693888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.